What is the recommended antibiotic for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Cellulitis

For typical non-purulent cellulitis, start with a 5-day course of an oral antibiotic active against streptococci: cephalexin, amoxicillin, dicloxacillin, or penicillin are first-line choices. 1

Treatment Algorithm Based on Clinical Presentation

Mild, Non-Purulent Cellulitis (Most Common)

  • Begin with streptococcal-targeted therapy using cephalexin, amoxicillin, dicloxacillin, or penicillin for 5 days 1
  • Beta-hemolytic streptococci are the primary pathogens in typical cellulitis, with S. aureus less frequently involved unless there is penetrating trauma or an underlying abscess 1
  • Extend treatment beyond 5 days only if no clinical improvement is evident 1
  • For penicillin-allergic patients, use clindamycin or erythromycin 1, 2

When to Add MRSA Coverage

Add MRSA-active antibiotics only when specific risk factors are present, not routinely 1:

  • Penetrating trauma
  • Evidence of MRSA infection elsewhere or nasal colonization
  • Injection drug use
  • Purulent drainage
  • Systemic inflammatory response syndrome (SIRS)
  • Athletes, prisoners, military recruits, long-term care residents, or men who have sex with men 3

For MRSA coverage, choose one of these regimens 1:

  • Clindamycin alone (covers both streptococci and MRSA)
  • TMP-SMX plus a beta-lactam (such as amoxicillin or cephalexin)
  • A tetracycline plus a beta-lactam

Severe Cellulitis Requiring Hospitalization

  • Use IV vancomycin for empiric MRSA coverage pending culture data 1
  • Alternative IV options include linezolid, daptomycin, or telavancin 1
  • For severely compromised patients, use vancomycin plus piperacillin-tazobactam or a carbapenem 1
  • Treatment duration is 7-14 days, individualized based on clinical response 1

Evidence Supporting Short-Course Therapy

  • Multiple studies demonstrate that 5-6 days of appropriate antibiotics achieve similar clinical outcomes to longer courses 1
  • The American College of Physicians and NICE guidelines both support 5-7 day treatment durations 1
  • In a Hawaii study with 62% MRSA prevalence, TMP-SMX achieved 91% success versus 74% for cephalexin, demonstrating the importance of local resistance patterns 4

Critical Pitfalls to Avoid

  • Do not routinely cover MRSA in typical cellulitis—this is the most common error, leading to unnecessary broad-spectrum antibiotic use 1, 3
  • Always examine interdigital toe spaces for fissuring, scaling, or maceration that may harbor pathogens and serve as entry points 1
  • Elevate the affected extremity—failure to do so delays clinical improvement 1
  • Do not obtain cultures routinely in typical cases; reserve blood cultures for patients with malignancy, severe systemic features, or unusual predisposing factors 1

Adjunctive Measures

  • Elevate the affected area to promote drainage of edema 1, 5
  • Treat predisposing conditions including tinea pedis, toe web abnormalities, edema, and venous insufficiency 1
  • Consider prednisone 40 mg daily for 7 days in non-diabetic adults to hasten resolution 1, 5

Prevention of Recurrence

  • Address underlying risk factors: obesity, venous insufficiency, lymphedema, and toe web infections 1
  • For patients with 3-4 episodes per year despite treating predisposing factors, use prophylactic oral penicillin or erythromycin twice daily for 4-52 weeks 1

References

Guideline

Cellulitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Guideline

Treatment of Preseptal Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.